Our mission is to reverse hypoxia. Hypoxia occurs when the body's cells don't get enough oxygen, this plays a significant role in various fatal diseases. We are committed to patient safety and ensuring their access to life-saving oxygen therapeutics.

NuvOx Pharma is a clinical stage pharmaceutical company developing a drug that improves the flow of oxygen from lungs to blood and from blood to tissue. Over 30 animal studies have shown therapeutic effect in seven different indications. Phase Ib/II clinical trials in stroke and oncology demonstrated safety and evidence of efficacy, and the company is preparing to run a trial in COVID-19 patients with Acute Hypoxemic Respiratory Failure (AHRF).